At a glance
- Originator Merck Sharp & Dohme
- Class Antiulcers; Gastric antisecretories
- Mechanism of Action Cholecystokinin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 03 Nov 1998 No-Development-Reported for Gastrointestinal disorders in United Kingdom (Unknown route)
- 03 Nov 1998 No-Development-Reported for Gastrointestinal disorders in USA (Unknown route)
- 29 Aug 1996 Preclinical development for Gastrointestinal disorders in United Kingdom (Unknown route)